Equitable Access to COVID-19 Vaccines

Covid19 Clinical Trial

Official title: Enabling Equitable Access to COVID-19 Vaccine in Under-Resourced Communities

Status Completed

Clinical Trial Summary

This study will deploy a multimodal pragmatic intervention to improve vaccine uptake in priority populations and address vaccine hesitancy to improve access by using a proactive organized population-based outreach leveraging health information technology with tailored navigation support to address mistrust and social barriers.

Clinical Trial Description

This study will deploy a multimodal pragmatic intervention to improve vaccine uptake in priority populations through a proactive organized population-based outreach approach. It will leverage health information technology with tailored navigation support to address mistrust and social barriers. Study key objectives are to:

1. conduct a survey of patients to assess and track barriers, intent, and sources of information on COVID vaccine over time.

2. Determine whether a primary care physician (PCP) endorsement with or without interactive digital communication plus navigation is more effective in promoting uptake of COVID-19 vaccine than general messages from the clinic. Patients will be randomized to one of three arms:

1. Arm 1: Message about vaccine availability delivered by SMS advising patients to make an appointment.

2. Arm 2: Same as Arm 1 but delivered as a personalized message text from the PCP.

3. Arm 3: Same as Arm 2 plus a interactive 2-way SMS options. ;

Related Conditions & MeSH terms

• COVID-19
• Covid19

• NCT number: NCT04952376
• Study type: Interventional
• Source: Mayo Clinic
• Status: Completed
• Phase: N/A
• Start date: April 1, 2021
• Completion date: June 10, 2021